# EDGAR Filing Document

**Accession Number:** 0001685397
**File Stem:** 0000877860-25-000164
**Filing Date:** 2025-9
**Character Count:** 7371
**Document Hash:** ef87ccc17789e46f1bce4bde98534e38
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000877860-25-000164.hdr.sgml**: 20250925

**ACCESSION NUMBER**: 0000877860-25-000164

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250924

**FILED AS OF DATE**: 20250925

**DATE AS OF CHANGE**: 20250925

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Travis David L
- **CENTRAL INDEX KEY:** 0001685397

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10822
- **FILM NUMBER:** 251344471

**MAIL ADDRESS:**
- **STREET 1:** C/O MEDEQUITIES REALTY TRUST
- **STREET 2:** 3100 WEST END AVENUE, SUITE 1000
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NATIONAL HEALTH INVESTORS INC
- **CENTRAL INDEX KEY:** 0000877860
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 621470956
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 222 ROBERT ROSE DRIVE
- **CITY:** MURFREESBORO
- **STATE:** TN
- **ZIP:** 37129
- **BUSINESS PHONE:** 6158909100

**MAIL ADDRESS:**
- **STREET 1:** 222 ROBERT ROSE DRIVE
- **CITY:** MURFREESBORO
- **STATE:** TN
- **ZIP:** 37129

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Travis David L<br><sub>(Last) (First) (Middle)</sub><br>222 ROBERT ROSE DRIVE<br><sub>(Street)</sub><br>MURFREESBORO, TN 37129<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-09-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_SVP/Chief Accounting Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>NATIONAL HEALTH INVESTORS INC [ NHI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-09-23 |  | M |  | 11666 | A | $69.20 | 33221 | D |  |
| Common Stock | 2025-09-23 |  | M |  | 11334 | A | $69.20 | 44555 | D |  |
| Common Stock | 2025-09-23 |  | F |  | 20765 | D | $80.06 | 23790 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Options (Right to Buy) 2-25-2021 | $69.20 | 2025-09-23 |  | M |  |  | 11666 | 2021-02-25 | 2026-02-25 | Common Stock | 11666 | $0 | 0 | D |  |
| Stock Options (Right to Buy) 2-25-2021 | $69.20 | 2025-09-23 |  | M |  |  | 11334 | 2022-02-25 | 2026-02-25 | Common Stock | 11334 | $0 | 0 | D |  |
| Stock Option (Right to buy) 2022 | $53.41 |  |  |  |  |  |  | 2023-02-25 | 2027-02-25 | Common Stock | 2404 |  | 2404 | D |  |
| Stock Option (Right to buy) 2022 | $53.41 |  |  |  |  |  |  | 2024-02-25 | 2027-02-25 | Common Stock | 9796 |  | 9796 | D |  |
| Stock Option (Right to Buy) 2023 | $54.73 |  |  |  |  |  |  | 2023-02-24 | 2028-02-24 | Common Stock | 8333 |  | 8333 | D |  |
| Stock Option (Right to Buy) 2023 | $54.73 |  |  |  |  |  |  | 2024-02-24 | 2028-02-24 | Common Stock | 8333 |  | 8333 | D |  |
| Stock Option (Right to Buy) 2023 | $54.73 |  |  |  |  |  |  | 2025-02-24 | 2028-02-28 | Common Stock | 8334 |  | 8334 | D |  |
| Stock Option (Right to Buy) 2024 | $57.76 |  |  |  |  |  |  | 2024-02-23 | 2029-02-23 | Common Stock | 8333 |  | 8333 | D |  |
| Stock Option (Right to Buy) 2024 | $57.76 |  |  |  |  |  |  | 2025-02-23 | 2029-02-23 | Common Stock | 8333 |  | 8333 | D |  |
| Stock Option (Right to Buy) 2024 | $57.76 |  |  |  |  |  |  | 2026-02-23 | 2029-02-23 | Common Stock | 8334 |  | 8334 | D |  |
| Stock Option (Right to Buy) 2025 | $73.34 |  |  |  |  |  |  | 2025-03-03 | 2030-03-03 | Common Stock | 10000 |  | 10000 | D |  |
| Stock Option (Right to Buy) 2025 | $73.34 |  |  |  |  |  |  | 2026-03-03 | 2030-03-03 | Common Stock | 10000 |  | 10000 | D |  |
| Stock Option (Right to Buy) 2025 | $73.34 |  |  |  |  |  |  | 2027-03-03 | 2030-03-03 | Common Stock | 10000 |  | 10000 | D |  |

---

**Signature:** /s/ David L. Travis  
**Date:** 2025-09-24

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**